Evaluating the effectiveness of a tailored multifaceted performance feedback intervention to improve the quality of care: protocol for a cluster randomized trial in intensive care by van der Veer, Sabine N et al.
Implementation
Science
Evaluating the effectiveness of a tailored
multifaceted performance feedback intervention
to improve the quality of care: protocol for a
cluster randomized trial in intensive care
van der Veer et al.
van der Veer et al. Implementation Science 2011, 6:119
http://www.implementationscience.com/content/6/1/119 (24 October 2011)STUDY PROTOCOL Open Access
Evaluating the effectiveness of a tailored
multifaceted performance feedback intervention
to improve the quality of care: protocol for a
cluster randomized trial in intensive care
Sabine N van der Veer
1*, Maartje LG de Vos
2,3, Kitty J Jager
1, Peter HJ van der Voort
4, Niels Peek
1,
Gert P Westert
2,5, Wilco C Graafmans
6 and Nicolette F de Keizer
1
Abstract
Background: Feedback is potentially effective in improving the quality of care. However, merely sending reports is
no guarantee that performance data are used as input for systematic quality improvement (QI). Therefore, we
developed a multifaceted intervention tailored to prospectively analyzed barriers to using indicators: the
Information Feedback on Quality Indicators (InFoQI) program. This program aims to promote the use of
performance indicator data as input for local systematic QI. We will conduct a study to assess the impact of the
InFoQI program on patient outcome and organizational process measures of care, and to gain insight into barriers
and success factors that affected the program’s impact. The study will be executed in the context of intensive care.
This paper presents the study’s protocol.
Methods/design: We will conduct a cluster randomized controlled trial with intensive care units (ICUs) in the
Netherlands. We will include ICUs that submit indicator data to the Dutch National Intensive Care Evaluation (NICE)
quality registry and that agree to allocate at least one intensivist and one ICU nurse for implementation of the
intervention. Eligible ICUs (clusters) will be randomized to receive basic NICE registry feedback (control arm) or to
participate in the InFoQI program (intervention arm). The InFoQI program consists of comprehensive feedback,
establishing a local, multidisciplinary QI team, and educational outreach visits. The primary outcome measures will
be length of ICU stay and the proportion of shifts with a bed occupancy rate above 80%. We will also conduct a
process evaluation involving ICUs in the intervention arm to investigate their actual exposure to and experiences
with the InFoQI program.
Discussion: The results of this study will inform those involved in providing ICU care on the feasibility of a tailored
multifaceted performance feedback intervention and its ability to accelerate systematic and local quality
improvement. Although our study will be conducted within the domain of intensive care, we believe our
conclusions will be generalizable to other settings that have a quality registry including an indicator set available.
Trial registration: Current Controlled Trials ISRCTN50542146
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To systematically monitor the quality of care and develop
and evaluate successful improvement interventions, data
on clinical performance are essential [1,2]. These perfor-
mance data are often based on a set of quality indicators,
ideally combining measures of structure, process, and out-
comes of care [3,4].
Also within the domain of intensive care, several indi-
cator sets have been developed [5-9], and numerous
quality registries have been established worldwide to rou-
tinely have indicator data available on the performance of
intensive care units (ICUs) [10-13]. In the Netherlands,
the National Intensive Care Evaluation (NICE) quality
registry was founded in 1996 by the Dutch intensive care
profession with the aim to systematically and continu-
ously monitor, assess, and compare ICU performance,
and to improve the quality of ICU care based on the out-
come indicators case-mix adjusted hospital mortality and
length of ICU stay [13]. In 2006, this limited core data set
of outcome indicators was extended to a total of eleven
structure, process, and outcome indicators, adding items
such as nurse-to-patient ratio, glucose regulation, dura-
tion of mechanical ventilation, and incidence of severe
pressure ulcers. The extended set was developed by the
Netherlands Society for Intensive Care (NVIC) in close
collaboration with the NICE foundation [7].
Besides facilitating data collection and analyses, NICE-
like most quality registries-also sends participants period-
ical feedback reports on their performance over time and
in comparison with other groups of ICUs. Although feed-
back is potentially effective in improving the quality of
care [14-16], merely sending feedback reports is no guar-
antee that performance data are used as input for sys-
tematic quality improvement (QI).
Problem: barriers perceived by health care professionals
to using performance feedback for systematic quality
improvement
Previous systematic reviews reported potential barriers at
different levels to using performance data for systematic
improvement of health care, e.g., insufficient data quality,
no acknowledgement of the room for improvement in
current practice, or lack of resources to implement qual-
ity interventions [15,16]. The results of a validated ques-
tionnaire completed by 142 health care professionals
working at 54 Dutch ICUs confirmed that such barriers
also exist within the context of intensive care [17]. As
suggested by others [18,19], we translated these prospec-
tively identified barriers into a multifaceted QI interven-
tion using input from future users, expert knowledge,
and evidence from literature. The table in ‘Additional file
1’ contains all barriers identified and how they are tar-
geted by the intervention. We named the resulting QI
program InFoQI (Information Feedback on Quality
Indicators). InFoQI was developed and will be evaluated
within the context of intensive care and the Dutch NICE
registry. By targeting the potential barriers to using per-
formance feedback as input for systematic QI activities at
ICUs, the InFoQI program ultimately aims to improve
the quality of intensive care.
Study objectives
The study as proposed in this protocol aims to evaluate
the effect of the tailored multifaceted feedback interven-
tion on the use of performance indicator data for systema-
tic QI at ICUs. Specific objectives include:
1. To assess the impact of the InFoQI program on
patient outcome and organizational process mea-
sures of ICU care.
2. To gain insight into the barriers and success fac-
tors that affected the program’s impact.
3. The InFoQI program was designed to overcome
the previously identified barriers to using perfor-
mance indicator data as input for local QI activities.
Based on this assumption we hypothesize that ICUs
participating in the InFoQI program will improve the
quality of their care significantly more than ICUs
receiving basic feedback from the NICE registry.
The results of this study will inform those involved in
providing ICU care on the feasibility of the InFoQI pro-
gram and its ability to accelerate systematic, local QI at
ICUs. More in general, we believe that our results might
be of interest to clinicians and organizations in any set-
ting that use a quality registry including performance
indicators to continuously monitor and improve the
quality of care.
Methods
Study design
We will execute a cluster randomized controlled trial to
compare facilities participating in the InFoQI program
(intervention arm) to facilities receiving basic feedback
from the NICE registry (control arm). Because the InFoQI
program will be implemented at the facility rather than
individual level, a cluster randomized trial is the preferred
design for the evaluation of the program’se f f e c t i v e n e s s
[20]. Like most trials aimed at evaluating organizational
interventions, our study is pragmatic [21]. To apply to cur-
rent standards, the study has been designed and will be
reported in accordance with the CONSORT statement
[22] and the appropriate extensions [23,24].
Setting
The setting of our study is Dutch intensive care. In the
Netherlands, virtually all 94 ICUs are mixed medical-
surgical closed-format units, i.e., units with the intensivist
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a mixture of academic, teaching, and nonteaching settings
in urban and nonurban hospitals. In 2005, 8.4 adult ICU
beds per 100,000 population were available, and 466
patients per 100,000 population were admitted to the ICU
that year [25]. Currently, a representative sample of 80
ICUs-covering 85% of all Dutch ICUs-voluntarily submit
the limited core data set to the NICE registry, and 46
of them collect the complete, extended quality indicator
data set.
At the NICE coordination center, dedicated data man-
agers, software engineers, and a coordinator are responsi-
ble for routine processing, storing, checking, and
reporting of the data. Also, for the duration of the study,
two researchers will be available to provide the InFoQI
program to ICUs in the intervention arm. The availability
of these resources is essential for the feasibility of our
study.
Selection of participants
All 46 ICUs that participate in NICE and (are preparing
to) submit data to the registry on the extended quality
indicator set will be invited to participate in our study.
They should be willing and able to allocate at least two
staff members for an average of four hours per month to
be involved in the study. The medical manager of the ICU
must sign a consent form to formalize the organization’s
commitment.
All patients admitted to participating ICUs during the
study period will be included in the analyses. However,
when evaluating the impact on patient outcomes, we will
exclude admissions based on the Acute Physiology and
Chronic Health Evaluation (APACHE) IV exclusion cri-
teria [26], as well as admissions following cardiac surgery,
patients who were dead on admission, and admissions
with any of the case mix variables missing.
Control arm: basic feedback from the NICE registry
The ICUs allocated to the control arm will be treated as
‘regular’ NICE participants. This implies they will receive
basic quarterly and annual feedback reports on the regis-
try’s core outcome indicators case-mix adjusted hospital
mortality and length of ICU stay. In addition, they will be
sent similar, but separate, basic quarterly and annual feed-
back reports containing data on the extended indicator
set. Also, support by the NICE data managers is available
and includes data quality audits, support with data collec-
tion, and additional data analyses on request. Furthermore,
they are invited to a yearly discussion meeting where they
can share experiences with other NICE participants.
Intervention arm: the InFoQI program
ICUs assigned to the intervention arm, i.e., participating in
the InFoQI program, will receive the same intervention as
the control arm, but extended with more frequent and
more comprehensive feedback, a local, multidisciplinary
QI team, and two educational outreach visits (Table 1).
From the prospective barriers analysis, it appeared that
many barriers concerned the basic NICE feedback reports.
To target the lack of case-mix correction and lack of infor-
mation to initiate QI actions, the basic quarterly report
will be replaced by an extended, comprehensive quarterly
report that facilitates comparison of an ICU’s performance
with that of other ICUs, e.g.,b yp r o v i d i n gt h em e d i a n
length of ICU stay for elective surgery admissions in simi-
lar-sized ICUs as a benchmark. To increase the timeliness
and intensity of reporting, we also developed a monthly
report focusing on monitoring an ICUs’ own performance
over time to facilitate local evaluation of QI initiatives, e.g.,
by providing Statistical Process Control (SPC) charts [27].
To decrease the level of data aggregation, both the
monthly and quarterly reports contain data at the level of
individual patients, e.g., a list of unexpected non-survivors
(i.e., patients who died despite their low risk of mortality).
The table in ‘Additional file 2’ summarizes the content of
the reports.
ICUs in the intervention arm will establish a local QI
team, creating a formal infrastructure at their department
for systematic QI. This team must consist of at least one
intensivist and one nurse; a management representative
and a data manager are suggested as additional members.
To target the lack of motivation to change, team members
should be selected based on their affinity and experience
with measuring and improving quality of care and their
capability to convince their colleagues to be involved in QI
activities. The team’s main tasks are described in a proto-
col and include formulating a QI action plan, monitoring
of performance using the feedback reports, and initiating
and evaluating QI activities (see Table 1). We estimate the
minimum time investment per team member to be four
hours on average per month. This estimation takes into
account all activities prescribed by the InFoQI program
except for the execution of the QI plan. The actual time
spent will depend on the type and number of QI actions
in the plan.
Each ICU will receive two on-site educational outreach
visits that are aimed at increasing trust in data quality, sup-
porting the QI team members with interpreting their per-
formance data, identifying opportunities for improvement,
and translating them into a QI action plan. The structure
of the visits will be equal for all intervention ICUs and the
template for the action plan will be standardized. All visits
will be facilitated by the same investigators who have a
non-medical background; they have been involved in the
development of the extended NVIC indicator set and have
several years of experience with optimization of organiza-
tional processes at the ICU. Having non-clinicians support-
ing the QI team will make the intervention less intrusive,
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increases the feasibility of the study, because clinical
human resources are scarce in intensive care.
Outcome measures
We used previously collected NICE data (regarding the
year 2008) to select outcome measures from the
extended quality indicator set to evaluate the effective-
ness of our intervention. To decrease the probability of
finding positive results by chance as a result of multiple
hypothesis testing [28], we limited our primary endpoints
to a combination of one patient outcome and one organi-
zational process measure. We selected the indicators that
showed the largest room for improvement, i.e., the largest
difference between the average of top-performing centers
and the average of the remaining centers [29].
Primary outcome measures will be:
1. Length of ICU stay (ICU LOS); this will be calcu-
lated as the difference in days between the time of ICU
discharge and time of ICU admission. To account for
patients being discharged too early, the length of stay
of the first ICU admission will be prolonged with the
length of stay of subsequent ICU readmissions within
the same hospital admission.
2. Proportion of shifts with a bed occupancy rate
above 80%; this threshold is set by the NVIC in their
national organizational guideline for ICUs [30]. We
will calculate the bed occupancy rate as the maxi-
mum number of patients admitted simultaneously
during an eight-hour nursing shift divided by the
number of operational beds in that same shift. A bed
will be defined as ‘operational’ when it is fitted with
monitoring and ventilation equipment and scheduled
nursing staff.
Secondary outcome measures will be all-cause, in-hos-
pital mortality of ICU patients, duration of mechanical
ventilation, proportion of glucose measurements outside
the range of 2.2 to 8.0 mmol/L, and the proportion of
shifts with a nurse-to-patient ratio below 0.5.
Data collection
We will use the existing data collection methods as cur-
rently applied by the NICE registry [31]. Most ICUs parti-
cipating in NICE combine manual entry of data using
dedicated software with automated data extractions from
electronic patient records available in, e.g.,t h e i rp a t i e n t
data management system. Each month, participants
upload their data from the local, electronic database to the
central, electronic registry database. ICUs in the interven-
tion arm that have not submitted their data at the end of a
month will be reminded by phone, and assisted if neces-
sary. Quarterly reports are provided within ten weeks after
the end of a period, and monthly reports within six weeks.
The NICE registry uses a framework for data quality
assurance [32], including elements like periodical on-site
data quality audits and automated data range and consis-
tency checks. For each ICU, additional data checks for
completeness and accuracy will be performed before, dur-
ing, and after the study period using descriptive statistics.
Sample size calculations
The minimally required number of ICUs participating in
the trial was based on analysis of the NICE registry 2008
data. First, ICUs were ranked by average ICU LOS of their
patients. The anticipated improvement was defined as the
difference in average ICU LOS of the 33% top ranked
ICUs (1.28 days) and average ICU LOS among the remain-
ing ICUs (2.11 days), and amounted to a reduction of 0.58
days per patient. A senior intensivist confirmed that this
reduction is considered clinically relevant. Assuming an
average number of 343 admissions per ICU per year, cal-
culations based on the normal distribution showed that
we will need at least 26 ICUs completing the trial to detect
this difference with 80% power at a type I error risk (a)o f
5%, taking an estimated intra-cluster correlation of 0.036
into account. With this number of ICUs, the study will
Table 1 Elements of the InFoQI program (intervention arm)
Element Description
Feedback ￿ monthly report for monitoring ICU’s performance over time
reports ￿ comprehensive quarterly report for benchmarking ICU’s performance to other
groups of ICUs
￿ sent to and discussed by QI team members
Local QI team ￿ multidisciplinary
￿ responsible for formulating and executing a QI action plan
￿ monthly monitoring and discussing of performance using feedback reports
￿ sharing main findings with rest of ICU staff
Educational outreach visits ￿ on-site (1) at start of study period and (2) after six months
￿ all QI team members are present; visits guided by principal investigators
￿ promoting use of Plan-Do-Study-Act cycle for systematic quality improvement
￿ formulating and evaluating QI action plan based on performance data
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mechanical ventilation duration of 0.75 days per patient
(from 2.96 to 1.75 days). We do not expect to be able to
detect an effect of the intervention on ICU or hospital
mortality.
To determine the required sample size for bed occu-
pancy, shifts with an occupancy exceeding 80% were
counted. This occurred in 44% of all shifts in 2008. Fol-
lowing the same ranking procedure as described above,
a reduction of 24% was anticipated, and considered
clinically relevant. Power calculations based on the bino-
mial distribution showed that we will need a minimum
of 16 ICUs completing the trial to detect this difference,
taking an estimated intra-cluster correlation of 0.278
into account.
Randomization
We will randomly allocate ICUs (clusters) to one of both
study arms, stratified by the number of ventilated, non-car-
diac surgery admissions (less than the national median ver-
sus more than the national median), and involvement in a
previous pilot study to evaluate feasibility of data collection
of the NVIC indicator set [7] (involved versus not involved).
Each stratum will consist of blocks with a randomly
assigned size of either two or four ICUs (see Figure 1). A
researcher-not involved in the study and blinded to the
identity of the units-will use dedicated software to generate
a randomization scheme with an equal number of interven-
tions and controls for each block. The size and the rando-
mization scheme of the blocks will be concealed to the
investigators enrolling and assigning the ICUs. In an email
to the ICU confirming the arm to which they have been
allocated, the researcher that executed the randomization
process will be sent this information in copy as an addi-
tional check on the assignment process. Due to the charac-
ter of the intervention, it will not be possible to blind
participants or the investigators providing the InFoQI
program.
Statistical analysis
For ICUs in the intervention group, the time from rando-
mization to the first outreach visit-with an expected
duration of six to eight weeks-will be regarded as a base-
line period. Follow-up will end three months after the
last report has been sent, assuming this is the average
time required for an ICU to read, discuss, and act on a
feedback report. The expected duration for intervention
ICUs will therefore be approximately fourteen months.
Control ICUs will have a fixed baseline period of two
months, and a follow-up of fourteen months.
To assess the effect of the InFoQI program, the out-
come values measured during the follow-up period will
be compared between both study arms. To assess the
effect of the program on length of stay, we will perform a
survival analysis of time to alive ICU discharge with
dying at the ICU as a competing risk [33], and adjusting
for patient demographics, severity of illness during first
24 hours of admission, and admission type. To account
for potential correlation of outcomes within ICUs, we
will use generalized estimation equations with exchange-
able correlation [34-36]. The same procedure will be
used to analyze duration of mechanical ventilation. For
all-cause mortality, logistic regression analysis will be
used, adjusting for severity of illness at ICU admission by
using the APACHE IV risk prediction model [26].
To assess the effect of the intervention on the propor-
tion of shifts with a bed occupancy rate above 80%,
shift-level occupancy data (0 for an occupancy rate
below or equal to 80%, 1 for a rate above 80%) will be
analyzed with logistic regression analysis. In this case,
generalized estimation equations with an autoregressive
correlation structure will be used to account for the
longitudinal nature of shift occupancy observations. The
same procedure will be followed to analyze the propor-
tion of shifts with a nurse-to-patient ratio below 0.5.
To assess the effect on the proportion of out-of-range
glucose measurements, multi-level logistic regression
analysis will be performed where subsequent glucose
measurements on the same patient are treated as time
series data, and both patient-level and ICU-level inter-
cept estimates are used to account for potential correla-
tion of measurements within patients and within ICUs.
Process evaluation
We will complement the quantitative trial results with the
results from a process evaluation to gain insight into the
barriers and success factors that affected the program’s
impact [37]. We will determine the actual exposure to the
InFoQI program by asking all members of the local QI
teams to record the time they have invested in the differ-
ent study activities. We will also investigate the experi-
ences of those exposed, and evaluate which of the barriers
identified before the start of the program were actually
solved, and if any other unknown barriers affected the pro-
gram’s impact; this might include barriers at the facility
level as well as at the individual level. Data will be col-
lected by sending an electronic questionnaire to all QI
team members at the end of the study period. They will be
asked to rate on a 5-point Likert scale to what extent they
perceived certain barriers to using the InFoQI program for
quality improvement at their ICU. In addition, we will
invite delegates of the local QI teams for a focus group to
discuss in more detail their experiences with the InFoQI
program and the barriers they perceived.
Ethics
The Institutional Review Board (IRB) of the Academic
Medical Center (Amsterdam, the Netherlands) informed
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deemed necessary due to the focus of the InFoQI program
on improving organizational processes; individual patients
will not be directly involved. Additionally, in the Nether-
lands there is no need to obtain consent to use data from
registries that do not contain patient-identifying
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ICUs assessed for eligibility 
Stratification * 
Block randomization 
Baseline measurement  Baseline measurement 
Allocation to intervention A  
(intervention arm) 
Allocation to intervention B  
(control arm) 
Participation in the InFoQI 
program 
Receiving basic feedback from 
the NICE registry 
Follow-up measurement  Follow-up measurement 
Process evaluation 
Figure 1 Study flow . * Stratification was based on size (more/less than the national median number of ventilated, non-cardiac surgery
admissions) and involvement (yes/no) in a pilot to evaluate feasibility of indicator data collection.
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foundation is officially registered according to the Dutch
Personal Data Protection Act.
Discussion
This paper describes the protocol of a cluster randomized
trial to evaluate the effect of the InFoQI program on the
quality of ICU care and a qualitative process evaluation
to gain insight into the barriers and success factors that
affected the program’s impact. The program-tailored to
prospectively identified barriers and facilitators-consists
of comprehensive feedback reports, establishing a local,
multidisciplinary QI team, and educational outreach vis-
its. We expect that this multifaceted intervention will
improve the quality of ICU care by enabling ICUs to
overcome known barriers to using performance data as
input for local QI activities.
Strengths and weaknesses of the study design
In our study, we used the previously developed NVIC
extended indicator set as the basis for our feedback inter-
vention. Although the NVIC is the national organization
representing the Dutch intensive care profession, some
ICUs may still disagree with the relevancy of some of the
indicators in the set. This would hinder the use of the
feedback as input for local QI activities, potentially
decreasing the effectiveness of the intervention. However,
disagreement with the content of the indicator set was
not identified as a barrier in our prospective barriers ana-
lysis. We will reassess this during the process evaluation.
Building on an existing indicator set also results in a
clear strength of our study, because we are able to use the
data collection methods as currently applied by the NICE
registry. This will increase the feasibility of the InFoQI
program, because eligible ICUs already routinely collect
the necessary data items as a result of their participation
in NICE; participation in the InFoQI program does not
require additional data collection activities. Furthermore,
the data quality assurance framework as applied by NICE
increases the reliability of the data [31,38], and all recom-
mended data quality control methods for QI projects [39]
are being accounted for in our study. This will minimize
the probability of missing and erroneous data.
Unfortunately, the design of the study will not allow us
to quantitatively evaluate the relative effectiveness of the
individual components of the InFoQI program. We con-
sidered a factorial design [40] for a separate evaluation of
the impact of the comprehensive feedback reports and the
outreach visits. However, the strong interconnectedness
between the two elements made this difficult. Further-
more, the program aims to successfully overcome known
barriers to using performance feedback for improving
practice. During the development process of the InFoQI
program, it became apparent that in order to achieve this
a combination of strategies would be required. Also, pre-
vious reviews of the literature reported that multifaceted
interventions seem to be more effective than single inter-
ventions [15,16,41]. Therefore, we will primarily focus on
evaluating the effectiveness of the program as a whole; yet,
the process evaluation will provide us with qualitative
information on how and to what extent each program ele-
ment might have contributed to this effectiveness.
As for the participants in our study, only ICUs that par-
ticipate in the NICE registry, are capable of submitting
indicator data, and agree to allocate resources to establish
a local QI team will be eligible for inclusion. These cri-
teria may lead to the selection of a non-representative
sample of ICUs, because eligible facilities are less likely to
be understaffed and more likely to have information
technology (IT) support to facilitate routine collection of
NICE data. This will not affect the internal validity of our
results, because both study arms will consist of these
early adopters. Moreover, the ‘earliest adopters’-i.e.,t h e
ICUs involved in the indicator pilot study [7]-should be
equally distributed between intervention and control
group as a result of our stratification method. However,
the generalizability of our findings will be limited to
ICUs that are motivated and equipped to systematically
monitor and improve the quality of the care they deliver.
Nevertheless, as the number of ICUs participating in
NICE is rapidly increasing, IT in hospitals is expanding,
and applying QI principles is becoming more common in
health care, we believe that this requirement will not
reduce the relevancy of our results for future ICU
practice.
Relation to other studies
The effectiveness of feedback as a QI strategy has often
been evaluated, as indicated by the large number of
included studies in systematic reviews on this subject
[14,15]. However, the number of studies comparing the
effect of feedback alone with the effect of feedback com-
bined with other strategies was limited and relatively few
evaluations regarded the ICU domain [14,42].
Previous before-after studies found a moderate effect of
performance feedback [43] and of multidisciplinary QI
teams [44] on the quality and costs of ICU care. How-
ever, many have advocated the need for rigorous evalua-
tions using an external control group to evaluate the
effect of QI initiatives [45-47], with the cluster rando-
mized trial usually being the preferred method [48,49].
There have been cluster RCTs in the ICU domain that
evaluated a multifaceted intervention with audit and
feedback as a basic element [50-52]. Some of them were
highly successful in increasing adherence to a specific
evidence-based treatment, such as the delivery of
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positioning to prevent ventilator-associated pneumonia
[50]. Our study will adopt a similar approach, combining
feedback with other strategies to establish change. Never-
theless, the InFoQI program will not focus on promoting
the uptake of one specific type of practice. Instead, we
assume that: an ICU will be prompted to modify practice
when they receive feedback on their performance being
low or inconsistent with that of other ICUs; the members
of the QI team are capable-with support of the facilita-
tors-to formulate effective actions based on this feedback;
and the resulting customized QI plan will contain QI
activities that are considered important and feasible
within the local context of the ICU. With the process
evaluation, we will learn if these assumptions were
correct.
Expected meaning of the study
The results of this study will inform ICU care providers
and managers on the feasibility of a tailored multifaceted
performance feedback intervention and its ability to accel-
erate systematic, local QI activities. However, the results
will also be of interest to other settings where national
quality registries including performance indicators are
used for continuous monitoring and improving care.
Furthermore, the quantitative effect measurement together
with the qualitative data from the process evaluation will
contribute to the knowledge on existing barriers to using
indicators for improving the quality of care and how they
can be effectively overcome.
Additional material
Additional file 1: Barriers to using performance data and how they
are targeted The prospectively identified barriers to using performance
data and how they are targeted by the feedback intervention
Additional file 2: Content of the feedback reports Summary of the
content of the quarterly and monthly InFoQI feedback reports
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